Is Benefitfocus (NASDAQ:BNFT) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We note that Benefitfocus, Inc. (NASDAQ:BNFT) does have debt on its balance sheet. But the more important question is: how much risk is that debt creating?

Advertisement

When Is Debt A Problem?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, plenty of companies use debt to fund growth, without any negative consequences. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

See our latest analysis for Benefitfocus

What Is Benefitfocus's Net Debt?

As you can see below, at the end of June 2019, Benefitfocus had US$183.7m of debt, up from US$128.4m a year ago. Click the image for more detail. However, it also had US$138.4m in cash, and so its net debt is US$45.3m.

NasdaqGM:BNFT Historical Debt, August 12th 2019
NasdaqGM:BNFT Historical Debt, August 12th 2019

How Healthy Is Benefitfocus's Balance Sheet?

We can see from the most recent balance sheet that Benefitfocus had liabilities of US$74.4m falling due within a year, and liabilities of US$279.9m due beyond that. Offsetting these obligations, it had cash of US$138.4m as well as receivables valued at US$42.5m due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$173.4m.

Benefitfocus has a market capitalization of US$862.9m, so it could very likely raise cash to ameliorate its balance sheet, if the need arose. However, it is still worthwhile taking a close look at its ability to pay off debt. When analysing debt levels, the balance sheet is the obvious place to start. But it is future earnings, more than anything, that will determine Benefitfocus's ability to maintain a healthy balance sheet going forward. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

Over 12 months, Benefitfocus reported revenue of US$273m, which is a gain of 10%. We usually like to see faster growth from unprofitable companies, but each to their own.

Caveat Emptor

Importantly, Benefitfocus had negative earnings before interest and tax (EBIT), over the last year. Indeed, it lost US$36m at the EBIT level. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. So we think its balance sheet is a little strained, though not beyond repair. Another cause for caution is that is bled US$19m in negative free cash flow over the last twelve months. So suffice it to say we do consider the stock to be risky. When I consider a company to be a bit risky, I think it is responsible to check out whether insiders have been reporting any share sales. Luckily, you can click here ito see our graphic depicting Benefitfocus insider transactions.

If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About NasdaqGM:BNFT

Benefitfocus

Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans in the United States.

Slightly overvalued with imperfect balance sheet.

Advertisement

Weekly Picks

VA
valuebull
GOAI logo
valuebull on Eva Live ·

Is this the AI replacing marketing professionals?

Fair Value:US$7.4342.5% undervalued
30 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7829.0% undervalued
32 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative
ST
WBD logo
SteveGruber on Warner Bros. Discovery ·

The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery  

Fair Value:US$18.1752.7% overvalued
5 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6435.3% undervalued
35 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative

Updated Narratives

VE
Vestra
KTOS logo
Vestra on Kratos Defense & Security Solutions ·

Kratos Defense & Security Solutions (KTOS): Scaling "Attritable" Dominance in a New Era of Aerial Conflict.

Fair Value:US$11821.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
BWXT logo
Vestra on BWX Technologies ·

BWX Technologies (BWXT): Powering the Nuclear Renaissance from Naval Depths to Medical Frontiers.

Fair Value:US$205.22.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
MRK logo
Vestra on Merck ·

Merck & Co. (MRK): Scaling the "Post-Keytruda Hill" Through Diversified Blockbusters.

Fair Value:US$144.4818.9% undervalued
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.377.2% undervalued
51 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59631.3% undervalued
1303 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.8% undervalued
1102 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative